Search Results: health/ (125)

A Denver-based medical marijuana edibles manufacturer has recalled nearly 1,000 products from dispensary shelves because of potentially harmful marijuana, according to an announcement from the Denver Department of Environmental Health.

Approximately 980 Mountain Medicine products are subject to a recall because they were made with marijuana flower from Good Meds, a Denver wholesale marijuana cultivator. Good Meds voluntarily recalled its marijuana flower, concentrates and edibles earlier this month after city inspectors found “a lack of effective controls in place to prevent and detect pesticide contamination, and the presence of potentially unsafe pesticide residues.”

The pesticides in question contained fungicides tebuconazole and myclobutanil, according to the Department of Environmental Health.

A new study found that people who are more likely to develop schizophrenia are more likely to try cannabis. It also found  new evidence that cannabis use can cause schizophrenia.

The number of pregnant women who use cannabis is  up more than 60% since 2002. While knowledge of how cannabis affects fetuses is limited, Dr. Nora Volkow, head of the National Institute on Drug Abuse, called it “cause for concern.”

The Duluth News Tribune looks examines the case for, and against,  treating PTSD with MED.

More experts say cannabis  should be prescribed before opiates, VICE reports.

Ohio doctors say they’re  reluctant to recommend MED.

An article from “The American Tribune” on an overdose from injecting cannabis  turned out to be fake news.

Connecticut has approved its first MED study,  to compare pain relief with an opiate in patients with fractured ribs. A Connecticut hospice will use cannabis to  reduce its dependence on opioids.

President Obama  granted clemency to 231 individuals. His total of more than 1,300 sentence commutations totals more than his 11 predecessors combined. Here’s the story of one of them,  Paul Free, who was serving a life sentence and is now eligible for parole in 2020.

Obama also granted  78 “pre-Christmas” pardons.

Vox examines how Obama has  reshaped the war on drugs, and how that legacy is will be jeopardized under President Trump. For one thing, Obama tended not to use the term “War on Drugs.”

A court ruled that Arizona MED users  can’t be convicted of DUI without evidence of impairment.

A Colorado man who drove impaired and  killed a motorcyclist was sentenced to 10 months in jail and two years probation.

A day after they opened, six unlicensed Cannabis Culture dispensaries were  raided and closed in Montreal. The 10 arrests included owner and “prince of pot” Marc Emery.

Spotted in D.C.: “ This is your brain on Jeff Sessions.

In Milton, Mass., a dispensary seeks to open in the historic “ Swift Hat Shop” building.

They opposed REC sales in Arizona.

Here’s your daily dose of pot news from the newsletter WeedWeek.

Several former executives of Insys Therapeutics, which sells the powerful opiate fentanyl, were arrested accused of “ bribing doctors, defrauding insurance companies, and fueling America’s opioid addiction crisis.” Insys contributed to successfully defeat Arizona’s November REC vote.

GW Pharmaceuticals reported some “pretty grim” quarterly numbers, but it could benefit from its anti-epilepsy experimental drug Epidolex which is in late stage clinical trials.

Bloomberg suggests there’s a Canadian pot-stock bubble.

Legalization in more states could depress California’s export market. And in another interesting piece by Madison Margolin, California’s “extract artisans” now have some legal protections from meth-lab laws.

Vice dives into regulatory tech which it calls the “ cannabis surveillance state.

Home grow system Leaf raised $2M.

Celebrity-branded weed costs about 24% more than unbranded. Forbes asks if the trend has gone too far.

Commercial landlords in northern California prepare for legalization.

Quartz profiles marketing company Octavia Wellness which throws pot parties for seniors.  The art world is joining efforts to re-brand cannabis.

The Denver Post’s Cannabist won most influential media source at the cannabis business awards.

A new study in Pharmacological Research, by Czech and Italian researchers, found that pot is an aphrodisiac. Read the study here.

Another study found that marijuana use may damage eyesight.

New York state wants patients to be able to access MED in hospitals. A study found that cannabis users have lower in-hospital mortality rates.

In an effort to reduce opioid use, Oregon wants opioid patients monitored for marijuana use. The health agency view on marijuana vis a vis opioid use is unclear.

The world’s first clinical trial to test MED for chemotherapy patients is beginning in Australia.

A device developed by Israeli start-up distributes “ nano-droplets” of CBD as a nutraceutical to relieve inflammation and pain is on sale in the U.S. KKTV looked at the cannabis research happening at Colorado State-Pueblo.

The U.S. is lagging Israel and other countries in cannabis research.

The Washington [state]CannaBusiness Association is starting a fund to support MED access for the needy.

 

Israel’s Teva Pharmaceuticals will start to distribute a medical cannabis inhaler developed by Syqe, an Israeli start-up that raised money from tobacco giant Philip Morris. The inhaler may also be tested with opiates.

An editorial in The Scientist says its unacceptable that the World Health Organization has not developed positions on legalization.

Toronto’s Hospital for Sick Children will begin a clinical trial of cannabis extracts containing CBD and THC for children with severe epilepsy.

A new study from Steep Hill Labs found that 83 percent of California weed wouldn’t pass Oregon’s testing standards. An industry report says Oregon’s strict regulations are crushing the state industry. Willamette Week reports that business conditions are pushing some entrepreneurs back to the underground market.

Rehab provider Spectrum Health Systems said a doctor was not to blame for revealing to a patient’s employer that she uses MED.

A survey of cannabis researchers finds out what they want from the government in order to pursue their work.

A Reason investigation finds that conservative authorities in Idaho “conspired to restrict a promising cannabis-derived seizure treatment.”

The National Fire Protection Association is developing fire safety standards for cannabis businesses.

The FDA will allow a late stage clinical trial for ecstasy as a treatment for PTSD.

Minnessota approved PTSD as a MED qualifying condition. New York approved chronic pain.

Canada’s legalization push is getting complicated. The much-anticipated task force report on legalizationhas been delayed. Meanwhile activists wonder why shops are getting raided if the government plans to legalize. For more see here.

Bill Blair a Canadian government official overseeing the issue appeared at a “ cash-for-access” fundraiser with cannabiz leaders that may have violated Liberal Party ethics guidelines. Blair defended recent raidssaying, “The only system for control is the existing legal regime. And we’re a society of laws,” he says.

That’s a lot of lotion.
Here’s your daily round-up of pot news, excerpted from the newsletter WeedWeek.
A report found that cannabis “ medicinals and personal care products” could be a $2 billion industry by 2020. Sales of high-CBD products are growing among non-traditional cannabis users.

The new REC states have big plans for pot taxes. The Cannabist alerts them to “ five immediate concerns” about the industry.

Kris Krane, president of consulting firm 4Front Ventures, pooh-poohs the notion of Big Pot.

“There isn’t some megalithic industry that exists today…The notion that there are these gigantic, big-money players running in to take this whole thing over is just a fiction. There’s no Philip Morris, no Anheuser-Busch, no cannabis division at Bank of America. Even the most successful company is still barely in the growth stage.”

September was the third-straight best-month-ever for Colorado dispensaries.

A company called CanPay has what it calls the first “legitimate” debit payment system for dispensaries. The customer pays with a QR code accessed on their phone.

The Post Office has few safeguards for stopping employees who intercept weed sent through the mail.

Employers in California will still be able to fire workers who test positive. The San Jose Mercury News piece mentions that near one drug testing lab in Colorado, workers who arrive with containers of someone else’s clean urine tend to heat it up in a nearby convenience store’s microwave.

Canadian firms appear to be gouging the government healthcare system by signing up veteran MED patients for expensive strains according to a Vice report. Canadian companies could also benefit if there’s a crackdown in the U.S.

The Toronto Stock Exchange halted trading of six surging cannastocks. Some market watchers think it’sstill too early to invest.

Heavy rains in southern Oregon will force growers to torch moldy crops. Some rural Colorado communities derive much needed revenue from pot.

Florida entrepreneurs are excited about MED.

Jamaica’s licensing authority received 89 applications.

Could Delaware become a tax-free cannabis haven?” Small-scale Northern California growers areadjusting to legalization.

The U.S. Surgeon General says most illegal drug users don’t receive treatment. Many of them don’t want or need treatment, Reason says.

A study suggests that cannabis use can weaken heart muscles, particularly in young men. Read it here.

The journal Science says that the lower potency of plants from the one federally-sanctioned grow ( the one in Mississippi) undermines studies conducted with those plants.

Scientists are working on a new drug that functions like MED without the psychoactive effect.

Recent studies suggest that cannabis use may have mental health benefits and could have a role in curtailing opiate use.

Viceland uncovers a U.K. network of underground MED providers who give it away to patients.

British Columbia Premier Christy Clark, a Liberal, said police had discovered pot and other drugs laced with the powerful opiate fentanyl. Vancounver police denied it.

Some researchers are starting to take psychedelics seriously, as therapy. Also see this.

Being labeled “organic” doesn’t necessarily mean a product isorganic, and sustainable growers in the cannabis industry have long struggled to find ways to differentiate themselves from those who co-opt that term. Now L’Eagle has become the first dispensary to receive the Certifiably Green Denver certification from the city.

One of the last true mom-and-pop dispensaries in the city, L’Eagle is run by Amy Andrle and her husband, John, who have always worked to ensure that their product is environmentally sustainable. From avoiding harmful sprays on the flower to implementing best practices from agricultural science, L’Eagle has fought to keep its product green since the dispensary began in 2010.

The president-elect may not be a hardliner, but he’s surrounded himself with them.

Here’s your daily round-up of pot-news, excerpted from the newsletter WeedWeek

The all-but-final Election Day tally is California, Massachusetts, Nevada and Maine legalized REC, whileFlorida, Arkansas, and North Dakota legalized MED.

Arizona rejected a REC measure. Montanans voted to allow a MED industry, though it remains contentious.

Arkansas Governor Asa Hutchinson (R), a legalization opponent and former DEA chief, said the process requires federal input. “It’s an example of the states innovating in a risky area, and certainly the states are leading on this, but we’re to a point that the federal government is going to have to readdress this,” he said. “This does not call for a state-by-state solution, it calls for … a national solution.”

This is an early indication that the cannabis industry will be harder for the Donald Trump administration to ignore than it was for the Obama administration.

Vice president elect Mike Pence (R) has replaced New Jersey Governor Chris Christie as head of Trump’s transition team. Both are known for their hardline stances against legalization, as is former New York City Mayor, Rudy Giuliani, a possible attorney general in the administration.

Several pieces speculate on what a Trump presidency means for legalization. Here are three:  The Cannabist, MJBiz, Reveal (Center for Investigative Reporting).

Drug Policy Alliance head Ethan Nadelmann said, “the federal government retains the power to hobble much of what we’ve accomplished…The progress we’ve made … will be very much at risk when Donald Trump enters the White House.”

Vivian Azer, a stock analyst with Cowen, predicts cannabis will be a low priority for Trump.

Rep. Earl Blumenauer (D.-Ore.), probably pot’s best friend in Congress, said he thinks the industry’s priorities for banking and tax reform could both pass a Republican Congress under President Trump.

 

It’s even classified as a chemical weapon.

Here’s your daily round-up of pot-news, excerpted from the newsletter WeedWeek. Download WeedWeek’s free 2016 election guide here.

Steep Hill, a testing lab, found that 84% of samples tested at its Berkeley facility over a 30-day period tested positive for pesticide residues, more than expected. Alarmingly, about 65% of samples tested positive for Myclobutanil, a common food pesticide that becomes highly toxic when heated.

1 2 3 13